Jessica Swartz Email & Phone Number

New York, New York, US

Leading a team responsible for Pfizer's manufacturing (PGS) strategy.

New York, New York, US

• Global commercial lead for Pfizer’s Phase 3 anti-TFPI mAb for hemophilia A and B patients.
• Lead a team of direct reports responsible for the global marstacimab launch strategy including messaging, positioning, packaging, branding, revenue and volume forecasts, competitive intelligence, market development and.

New York, New York, US

• Global commercial lead for Pfizer’s next-generation adult pneumococcal vaccine (PCV20) launch.
• Collaborate with cross-functional stakeholders (medical, access, market research, regulatory, manufacturing, etc.) to develop commercial strategies, scientific narratives, marketing campaigns, and competitive.
• Oversee PCV20 budget and yearly forecasting.

New York, New York, US

• Strategic thought leader involved in positioning, launch strategies, commercial scenario planning, and forecasting.
• Developed incremental growth strategies, PCV20 risk mitigation plans, disease area strategies, go-to-market models and forecasts, preclinical asset business cases, and early-, mid- and late-stage US and global launch.
• Lead a team of 8-9 direct reports with a focus on learning, growth, and skills and career development.

New York, New York, US

• Successfully drove COVID-19 vaccine launches in over 75 markets in under 6 months.
• Responsible for launch readiness planning, including ‘last mile logistics’ to ensure countries around the world could receive, handle, store, administer and distribute Pfizer’s COVID-19 vaccine.
• Managed rapid turnaround of product profile and Life Cycle Management changes.
• Managed transition from “pandemic” period to “business as usual” period.
• Worked with BioNTech “Joint Commercial Council” to collaborate launch and commercial efforts across the alliance.

New York, New York, US

• Led Pfizer’s $22B Essential Health strategy team responsible for driving long- and short-term growth across businesses and geographies.
• Key focus areas included infectious disease, biologics, sterile injectables, and Emerging Markets.
• Led “Organizing for Growth” Project Management Organization. Collaborated directly with Pfizer’s ELT and Global Presidents to successfully achieve large organizational and management change during the creation of Upjohn.

New York, NY, US

New York, NY, US

Chair of the Academic Affairs committee and member of the NYU Board of Trustees responsible for, among other things, creating policy, setting mission and purpose, strategic planning, reviewing programs, fund-raising, alumni outreach, and community outreach.

• Regenovation is a preclinical-stage biotech start-up focused on the field of regenerative medicine. The company’s lead program is a platform technology designed to regrow cartilage in the knee.
• Responsible for company operations as well as developing and implementing business strategy and tactics, including creation and expansion of scientific, clinical, commercial, and business plans and value narratives for.
• Led business development efforts (e.g., search, evaluate, negotiations) to manage portfolio growth and life cycle management across multiple therapy areas.
• Reported directly to the CEO and represented the company with the Board, investors, and scientific advisors.

New York, New York, US

• Conducted strategic R&D, commercial & competitive analyses across multiple CNS disorders in partnership with BD.
• As a core member of NewCo externalization effort, developed business plans, identified portfolio growth opportunities, and negotiated with Venture Capital firms and leading strategic partners.

Danbury, CT, US

• Conducted pharmaceutical and biotech product, portfolio, and pipeline strategy analyses across a wide variety of therapy areas (endocrinology, gastroenterology, psychiatry, neurology, pain, rheumatology).
• Developed clinical and commercial development strategies, launch strategy, patient and HCP journeys, field force sizing analyses, and promotional tactics.
• Created long-term strategic plans and short-term tactics based on competitive intelligence, regulatory, payer, and provider dynamics.

Phd, Neuroscience

Ma, Neuropsychology

Ba, Germanic Language And Literature